Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
368,659,889
-
Total 13F shares
-
25,444,505
-
Share change
-
+695,786
-
Total reported value
-
$716,732,000
-
Price per share
-
$28.16
-
Number of holders
-
60
-
Value change
-
+$16,894,703
-
Number of buys
-
35
-
Number of sells
-
25
Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) as of Q4 2020
As of 31 Dec 2020,
Legend Biotech Corp - Ordinary Shares (LEGN) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,444,505 shares.
The largest 10 holders included
Vivo Capital, LLC, Charles Winkler, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., CAPITAL INTERNATIONAL INC, FEDERATED HERMES, INC., Johnson & Johnson Innovation - JJDC, Inc., ALLIANCEBERNSTEIN L.P., Capital World Investors, and FRANKLIN RESOURCES INC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.